Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

This study has been terminated.

Study NCT00003561 Information provided by Sidney Kimmel Comprehensive Cancer Center

First Received: November 1, 1999 Last Updated: July 19, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	August 2010
Primary Completion Date:	October 2001 (Final data collection date for primary outcome measure)